Who published this market news?

TradingView published this market news item.

Alzamend Neuro director Lynne Fahey McGrath dies; board expresses condolences

Alzamend Neuro announced the passing of director Lynne Fahey McGrath, M.P.H., Ph.D.Key Highlights:Original SEC Filing: Alzamend Neuro, Inc. [ ALZN ] - 8-K - Jul. 21, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note…

Alzamend Neuro announced the passing of director Lynne Fahey McGrath, M.P.H., Ph.D.

Key Highlights:

Lynne Fahey McGrath, a director since Alzamend Neuro's June 2021 IPO, died on July 20, 2026.
The board praised her governance, biopharmaceutical expertise and significant contributions to strategy.
Chairman William B. Horne said she was deeply missed and extended condolences to her family and friends.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.